Comparing the E2F6 cDNA levels at different tumor stages (Figure 3B) revealed each stage to have significantly more cDNA than normal tissue, especially when using E2F6 common primers (P < 0.001; Mann–Whitney U test), with a trend to suggest that expression may increase further as the tumor progresses. Here, E2F6 is linked to neoplasm.